| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |